Literature DB >> 30232834

Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials.

Changli Zhou1, Enfa Zhao2, Yuewei Li1, Yong Jia1, Feng Li1.   

Abstract

BACKGROUND: As drug use has limitations in the treatment of irritable bowel syndrome (IBS), increasing attention is being paid to nondrug therapies and complementary treatments, especially exercise. It is known that bowel movements are more frequent and colon transit is more rapid in physically active individuals than in sedentary individuals. However, the effects of exercise on IBS are unclear.
PURPOSE: We conducted a systematic review to assess the effects of exercise on IBS.
METHODS: We searched PubMed, Web of Science, EMBASE, Cochrane Library, and two Chinese databases (Wanfang Database and Chinese Biomedical Literature [CBM]) for eligible studies. We extracted and pooled relevant information regarding the effects of exercise in patients with IBS. The primary outcomes were gastrointestinal symptoms, quality of life, depression, and anxiety. KEY
RESULTS: A total of 683 patients with IBS from 14 randomized controlled trials met our inclusion criteria. The exercise interventions in this review were yoga, walking/aerobic physical activity, Tai Ji, mountaineering, and Baduanjin qigong activity. The results of this review suggested exercise had significant benefits for patients with IBS, but studies were limited by the strong risk of bias. CONCLUSIONS AND INFERENCES: Our findings suggest that exercise is potentially a feasible and effective treatment for IBS patients. However, because of methodologic issues, no firm conclusions could be drawn about the true effects of this intervention. Researchers should design a rigorous study to assess the effects of exercise on IBS.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  exercise; irritable bowel syndrome; randomized controlled trial; review

Mesh:

Year:  2018        PMID: 30232834     DOI: 10.1111/nmo.13461

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  10 in total

1.  Functional dyspepsia is associated with lower exercise levels: A population-based study.

Authors:  Natasha A Koloski; Michael Jones; Marjorie M Walker; Gerald Holtmann; Nicholas J Talley
Journal:  United European Gastroenterol J       Date:  2020-03-30       Impact factor: 4.623

Review 2.  Physical activity for treatment of irritable bowel syndrome.

Authors:  David Nunan; Ting Cai; Antoni D Gardener; José M Ordóñez-Mena; Nia W Roberts; Elizabeth T Thomas; Kamal R Mahtani
Journal:  Cochrane Database Syst Rev       Date:  2022-06-29

Review 3.  Best management of irritable bowel syndrome.

Authors:  Christopher J Black; Alexander Charles Ford
Journal:  Frontline Gastroenterol       Date:  2020-05-28

4.  Comparison of Taiji and aerobic exercise for functional constipation: study protocol for a randomised controlled neuroimaging trial.

Authors:  Sha Yang; Jingwen Chen; Yuyi Guo; Yuke Teng; Tianyu Liu; Rongtao Ying; Zhaoxuan He; Jianwei Wu; Shu-Guang Yu; Fang Zeng
Journal:  BMJ Open       Date:  2019-08-30       Impact factor: 2.692

Review 5.  Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions.

Authors:  David J Cangemi; Brian E Lacy
Journal:  Therap Adv Gastroenterol       Date:  2019-10-04       Impact factor: 4.409

6.  Multiple areas of the cerebral cortex influence the stomach.

Authors:  David J Levinthal; Peter L Strick
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

Review 7.  Review of Clinical Trials on the Effects of Tai Chi Practice on Primary Hypertension: The Current State of Study Design and Quality Control.

Authors:  Yuke Teng; Sha Yang; Yuan Chen; Yuyi Guo; Yushi Hu; Pan Zhang; Jingya Cao; Xinyue Zhang; Yalan Chen; Caili Jiang; Tianyu Liu; Fang Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-30       Impact factor: 2.629

8.  Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.

Authors:  Shin Fukudo; Toshikatsu Okumura; Masahiko Inamori; Yusuke Okuyama; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Akiko Shiotani; Yuji Naito; Yoshiko Fujikawa; Ryota Hokari; Tastuhiro Masaoka; Kazuma Fujimoto; Hiroshi Kaneko; Akira Torii; Kei Matsueda; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-02-04       Impact factor: 7.527

Review 9.  Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis.

Authors:  Caterina Carco; Wayne Young; Richard B Gearry; Nicholas J Talley; Warren C McNabb; Nicole C Roy
Journal:  Front Cell Infect Microbiol       Date:  2020-09-09       Impact factor: 5.293

10.  Buspirone in the management of refractory irritable bowel syndrome: A case report.

Authors:  Mustafa Abdul Karim; Nadeen Al-Baz; Peter M Haddad; Shuja M Reagu; Majid Alabdulla
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.